HOME › DRUGS › SIMEPREVIR
ACTIVE SUBSTANCE / INN

SIMEPREVIR

Brand name(s): Olysio
EMA LISTED
WITHDRAWN
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Simeprevir
REGULATORS
EMA
SPONSORS / MAH
Janssen-Cilag International NV
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OlysioJanssen-Cilag International NVWithdrawn14/05/2014Hepatitis C, Chronic

FULL INTELLIGENCE ON SIMEPREVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →